R Preston Mason

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Cardiovascular Disease

Coronary Artery Bypass Grafting

Top Venues

Current atherosclerosis reports

Journal of the American Heart Association

Cardiovascular research

This page only lists publications with an associated author ORCID identifier.

Publications

Samuel C R Sherratt, Peter Libby, Hazem Dawoud, Deepak L Bhatt, R Preston Mason
Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation. Journal of the American Heart Association 13 (14) (2024)
Samuel C R Sherratt, R Preston Mason, Peter Libby, Phillippe Gabriel Steg, Deepak L Bhatt
Do patients benefit from omega-3 fatty acids? Cardiovascular research 119 (18) (2024)
Samuel C R Sherratt, Peter Libby, Hazem Dawoud, Deepak L Bhatt, R Preston Mason
Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation. Journal of the American Heart Association (2024)
Samuel C R Sherratt, Peter Libby, Hazem Dawoud, Deepak L Bhatt, R Preston Mason
Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation. Journal of the American Heart Association 13 (14) (2024)
Samuel C R Sherratt, Peter Libby, Hazem Dawoud, Deepak L Bhatt, R Preston Mason
Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation. Journal of the American Heart Association 13 (14) (2024)
Samuel C R Sherratt, R Preston Mason, Peter Libby, Phillippe Gabriel Steg, Deepak L Bhatt
Do patients benefit from omega-3 fatty acids? Cardiovascular research 119 (18) (2024)
Samuel C R Sherratt, Peter Libby, Deepak L Bhatt, R Preston Mason
Comparative Effects of Mineral Oil, Corn Oil, Eicosapentaenoic Acid, and Docosahexaenoic Acid in an In Vitro Atherosclerosis Model. Journal of the American Heart Association (2023)
Samuel C R Sherratt, Peter Libby, Matthew J Budoff, Deepak L Bhatt, R Preston Mason
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues. Current atherosclerosis reports 25 (1) (2022)
Samuel C R Sherratt, Peter Libby, Matthew J Budoff, Deepak L Bhatt, R Preston Mason
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues. Current atherosclerosis reports (2022)
Samuel C R Sherratt, Peter Libby, Matthew J Budoff, Deepak L Bhatt, R Preston Mason
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues. Current atherosclerosis reports 25 (1) (2022)
Samuel C R Sherratt, Peter Libby, Matthew J Budoff, Deepak L Bhatt, R Preston Mason
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues. Current atherosclerosis reports 25 (1) (2022)
Samuel C R Sherratt, Peter Libby, Matthew J Budoff, Deepak L Bhatt, R Preston Mason
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues. Current atherosclerosis reports 25 (1) (2022)
Paul M Ridker, Nader Rifai, Jean MacFadyen, Robert J Glynn, Lixia Jiao, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Jean Claude Tardif, Christie M Ballantyne, R Preston Mason, Deepak L Bhatt
Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy. Circulation 146 (5) (2022)
Arjun Majithia, Deepak L Bhatt, Allon N Friedman, Michael Miller, Phillippe Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle, Craig Granowitz, Matthew J Budoff, R Preston Mason, Jean Claude Tardif, William E Boden, Christie M Ballantyne
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL. Circulation 144 (22) (2021)
Subodh Verma, Deepak L Bhatt, Phillippe Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Nitish K Dhingra, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle, Craig Granowitz, C Michael Gibson, Duane Pinto, Robert P Giugliano, Matthew J Budoff, R Preston Mason, Jean Claude Tardif, Christie M Ballantyne, null null
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG. Circulation 144 (23) (2021)